Delivery Order SPE2DB20D7059-SPE2DB23FQGL1
Award Date 8/16/23
Potential Completion Date 8/17/23
Potential Value $37
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $9,360 delivery order to Amerisourcebergen Drug Corporation for 4561866924 Banophen 25 mg capsules in quantities of 100. The firm fixed price order is to supply 100 counts of the specified medication to a location in Conshohocken, Pennsylvania by August 21, 2023. Amerisourcebergen will perform as the prime contractor, with the Defense Logistics Agency as the funding agency. This delivery order was issued under an existing DLA pharmaceuticals contract...
- The Defense Logistics Agency awarded a $13,270 delivery order to Amerisourcebergen Drug Corporation for 4561408551 Banophen 25 mg capsules in quantities of 1,000. The firm fixed price order is to supply pharmaceutical products to locations in Conshohocken, Pennsylvania, with performance required from July 5-6, 2023. Amerisourcebergen will deliver the requested pharmaceutical supplies under the DLA's prime vendor program, through which it provides medical materiel in support of the Department...
- The Defense Logistics Agency awarded a $10,500 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561585086 Banophen 25 mg capsules in a quantity of 24. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is July 24, 2023 through July 25, 2023. As the DLA is responsible for worldwide logistics support of the U.S. military, this delivery order was likely placed to support the agency's medical supply...
- The Defense Logistics Agency awarded a $17,900 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561504657 Banophen 25 mg capsules in quantities of 1,000. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The delivery order has a period of performance starting on July 14, 2023 and ending on July 17, 2023. No major subcontractors or set aside designations were identified. The Defense Logistics Agency supports America's...
- The Defense Logistics Agency awarded a $14,040 delivery order to Amerisourcebergen Drug Corporation for 4561557347 Banophen 25 mg capsules in quantities of 100. The firm fixed price order is for product delivery to a location in Conshohocken, Pennsylvania by July 21, 2023 in support of DLA's medical supply procurement programs. Amerisourcebergen will serve as the prime contractor on this small order, with no information provided regarding major subcontractors. The funding agency, DLA, oversees...
- The Defense Logistics Agency awarded a $16,350 delivery order to Amerisourcebergen Drug Corporation for 4562026647 Banophen 25 mg tablets. As the prime contractor, Amerisourcebergen will supply 24 tablets of Banophen 25 mg to fulfill DLA requirements under a firm fixed price contract. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a period of four days from September 1 through September 5, 2023. No subcontractors or set aside designations were...
- The Defense Logistics Agency awarded a $49,680 delivery order to Amerisourcebergen Drug Corporation for 4562245047 Banophen 25 mg tablets. Under this firm fixed price contract, Amerisourcebergen will provide 24 bottles of Banophen to support the Defense Logistics Agency's pharmaceutical supply needs. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania between September 20-21, 2023. No subcontractors or set aside designations were specified. This delivery...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $17,900 to Amerisourcebergen Drug Corporation for 4562180688 Banophen 25 mg capsules in 1000 count bottles. The place of performance is Amerisourcebergen's corporate office and distribution facility located in Conshohocken, Pennsylvania. The order is to be completed by September 15, 2023 and will supply the Defense Logistics Agency with pharmaceutical products in support of U.S. Department of Defense readiness and...
- The Defense Logistics Agency awarded Amerisourcebergen Drug Corporation a firm fixed price delivery order valued at thirty-five thousand ten dollars to provide one hundred units of twenty-five milligram Banophen capsules. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a period of one day, from July twelfth through July thirteenth of twenty twenty-three. As a top supplier to the Department of Defense, Amerisourcebergen will deliver these pharmaceutical...
- The Defense Logistics Agency awarded Amerisourcebergen Drug Corporation a firm fixed price delivery order valued at $11,700 for 4561918357 Banophen 25 mg capsules. As the prime contractor, Amerisourcebergen will supply 100 capsules to be delivered by August 24, 2023 to its Conshohocken, Pennsylvania facility. No subcontractors or set aside designations were indicated. The Defense Logistics Agency routinely issues delivery orders against various pharmaceutical distribution contracts to support...
- SPE2DB20D7059Indefinite Delivery Contract
- SPE2DB20D7059-SPE2DB23FQGL1Delivery Order
The Defense Logistics Agency awarded a firm fixed price delivery order valued at $37,160 to Amerisourcebergen Drug Corporation for the supply of 1,000 capsules of 50mg Banophen. The order was placed under an existing Prime Vendor contract vehicle to support DLA pharmaceutical procurement needs. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania by August 17, 2023. No set aside designation or subcontractors were identified for this order to fulfill DLA's pharmaceutical stock requirements.
Generated 12/20/23, 12:11 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $37 | 8/16/23 |